News Bio-Thera Solutions, Ltd.

Equities

688177

CNE100003R98

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
31.43 ^CNY	+4.04%		+8.45%	-23.79%

Mar. 25	Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006	CI
Mar. 20	Bio-Thera Solutions Grants Marketing Rights of Two Drugs to Latin American Company	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Thera Solutions Receives IND Clearance from US FDA to Initiate a Phase II Study for BAT8006, an Innovative Antibody Drug Conjugate Targeting Folate Receptor	Mar. 26	AQ
Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006	Mar. 25	CI
Bio-Thera Solutions Grants Marketing Rights of Two Drugs to Latin American Company	Mar. 20	MT
Bio-Thera Solutions, Ltd. Partners with SteinCares to Market Two Biosimilars in LATAM	Mar. 18	CI
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Bio-Thera Solutions Announces Initiation of Phase IB / IIA Clinical Trial for BAT6026	Feb. 01	CI
Bio-Thera Solutions Gets Regulatory Nod for Trial of Tumor Drug Combination Treatment	Jan. 12	MT
Recent Biosimilar Approvals	Dec. 21	AQ
Bio-Thera Solutions Wins US FDA Nod to Market Cancer Drug	Dec. 08	MT
FDA Approves Bio-Thera Solutions' Avzivi (Bevacizumab-Tnjn), A Biosimilar Referencing Avastin	Dec. 07	CI
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara	Nov. 29	CI
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litigation in the U.S	23-10-25	AQ
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement	23-10-24	MT
Roche, Biogen Settle US Patent Infringement Case Over Actemra Biosimilar	23-10-23	MT
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug	23-10-23	RE
Bio-Thera Partner Gets US FDA Marketing Nod for Arthritis Injectable	23-10-09	MT
FDA Approves Bio-Thera Solutions, Ltd.'s Partner Biogen Receives Notification from the United States Food and Drug Administration	23-10-08	CI
Biogen Says US FDA Approves Tocilizumab Biosimilar Tofidence	23-09-29	MT
Biogen's Tofidence Intravenous Formulation Gets FDA Approval	23-09-29	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bio-Thera Solutions, Ltd.

Equities

688177

CNE100003R98

Summary

Filters